These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6387488)

  • 1. The premenstrual syndrome. Effects of "medical ovariectomy".
    Muse KN; Cetel NS; Futterman LA; Yen SC
    N Engl J Med; 1984 Nov; 311(21):1345-9. PubMed ID: 6387488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premenstrual syndrome.
    Vaitukaitis JL
    N Engl J Med; 1984 Nov; 311(21):1371-3. PubMed ID: 6387490
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis.
    Wyatt KM; Dimmock PW; Ismail KM; Jones PW; O'Brien PM
    BJOG; 2004 Jun; 111(6):585-93. PubMed ID: 15198787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist--a preliminary report.
    Slater JE; Raphael G; Cutler GB; Loriaux DL; Meggs WJ; Kaliner M
    Obstet Gynecol; 1987 Oct; 70(4):542-6. PubMed ID: 3306508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
    Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR
    N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of vitamin B6 supplementation on premenstrual symptoms.
    Kendall KE; Schnurr PP
    Obstet Gynecol; 1987 Aug; 70(2):145-9. PubMed ID: 3299182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual syndrome.
    DeMonico SO; Brown CS; Ling FW
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):499-502. PubMed ID: 7893953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria.
    Anderson KE; Spitz IM; Bardin CW; Kappas A
    Arch Intern Med; 1990 Jul; 150(7):1469-74. PubMed ID: 2196028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
    Smith S; Rinehart JS; Ruddock VE; Schiff I
    Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
    Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
    Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms of premenstrual syndrome and their association with migraine headache.
    Martin VT; Wernke S; Mandell K; Ramadan N; Kao L; Bean J; Liu J; Zoma W; Rebar R
    Headache; 2006 Jan; 46(1):125-37. PubMed ID: 16412160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.
    Comite F; Shawker TH; Pescovitz OH; Loriaux DL; Cutler GB
    N Engl J Med; 1984 Oct; 311(16):1032-6. PubMed ID: 6434946
    [No Abstract]   [Full Text] [Related]  

  • 20. Menstruation and mental health: what's the chance of talking about that?
    Barrowman D
    Menopause Int; 2012 Jun; 18(2):87-9. PubMed ID: 22611229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.